replicateBE: Average Bioequivalence with Expanding Limits (ABEL)
Performs comparative bioavailability calculations for Average
    Bioequivalence with Expanding Limits (ABEL). Implemented are 'Method A' /
    'Method B' and the detection of outliers. If the design allows, assessment
    of the empiric Type I Error and iteratively adjusting alpha to control the
    consumer risk. Average Bioequivalence - optionally with a tighter (narrow
    therapeutic index drugs) or wider acceptance range (South Africa: Cmax) -
    is implemented as well.
| Version: | 
1.1.3 | 
| Depends: | 
R (≥ 3.5.0) | 
| Imports: | 
readxl (≥ 1.0.0), PowerTOST (≥ 1.5.3), lmerTest, nlme, pbkrtest, graphics, grDevices | 
| Suggests: | 
knitr, rmarkdown, testthat, devtools | 
| Published: | 
2022-05-02 | 
| Author: | 
Helmut Schütz  
    [aut, cre],
  Michael Tomashevskiy [ctb],
  Detlew Labes  
    [ctb] | 
| Maintainer: | 
Helmut Schütz  <helmut.schuetz at bebac.at> | 
| BugReports: | 
https://github.com/Helmut01/replicateBE/issues | 
| License: | 
GPL (≥ 3) | 
| URL: | 
https://github.com/Helmut01/replicateBE | 
| NeedsCompilation: | 
no | 
| Materials: | 
README NEWS  | 
| In views: | 
ClinicalTrials | 
| CRAN checks: | 
replicateBE results | 
Documentation:
Downloads:
Linking:
Please use the canonical form
https://CRAN.R-project.org/package=replicateBE
to link to this page.